Related Experiment Videos
[Carnitine-deficient cardiomyopathy]
K Kádár1, B Melegh, E Szendrei
1Országos Kardiológiai Intézet, Budapest.
Orvosi Hetilap
|February 27, 1994
Summary
Carnitine deficiency in an infant caused neuromuscular and cardiac issues. Oral L-carnitine therapy led to significant improvements in neurological and cardiac function, marking a successful treatment.
Area of Science:
- Pediatric Cardiology
- Neuromuscular Disorders
- Metabolic Diseases
Background:
- Carnitine deficiency is a rare metabolic disorder.
- It can manifest with severe neuromuscular and cardiac symptoms, including dilated cardiomyopathy.
- Early diagnosis and intervention are crucial for patient outcomes.
Observation:
- A 10-month-old infant presented with symptoms suggestive of carnitine deficiency.
- The infant exhibited significant neuromuscular impairment and cardiomyopathy.
- This case represents a rare instance of infantile dilated cardiomyopathy.
Findings:
- Treatment with oral L-carnitine was initiated.
- The infant showed a dramatic improvement in neurological status.
- Cardiac function also saw substantial recovery following L-carnitine supplementation.
Implications:
- This case highlights the efficacy of oral L-carnitine in treating carnitine deficiency-induced cardiomyopathy in infants.
- It underscores the importance of considering metabolic disorders in pediatric cardiomyopathy.
- Successful treatment with L-carnitine offers a promising therapeutic strategy for similar cases.